-
1
-
-
1242273853
-
ADMA: A novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease
-
10.1016/S1567-5688(03)00030-8 14664899
-
Boger RH, Zoccali C (2003) ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Atheroscler Suppl 4:23-28
-
(2003)
Atheroscler Suppl
, vol.4
, pp. 23-28
-
-
Boger, R.H.1
Zoccali, C.2
-
2
-
-
0023667668
-
Occurrence of a new enzyme catalyzing the direct conversion of NG, NG-dimethyl-l-arginine to l-citrulline in rats
-
10.1016/0006-291X(87)90929-6 1:CAS:528:DyaL1cXltFOnsg%3D%3D 3689365
-
Ogawa T, Kimoto M, Sasaoka K (1987) Occurrence of a new enzyme catalyzing the direct conversion of NG, NG-dimethyl-l-arginine to l-citrulline in rats. Biochem Biophys Res Commun 148:671-677
-
(1987)
Biochem Biophys Res Commun
, vol.148
, pp. 671-677
-
-
Ogawa, T.1
Kimoto, M.2
Sasaoka, K.3
-
3
-
-
0026548912
-
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
-
10.1016/0140-6736(92)90865-Z 1:STN:280:DyaK387mslOisw%3D%3D 1347093
-
Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575
-
(1992)
Lancet
, vol.339
, pp. 572-575
-
-
Vallance, P.1
Leone, A.2
Calver, A.3
Collier, J.4
Moncada, S.5
-
4
-
-
34249817585
-
The pharmacodynamics of l-arginine
-
17513442
-
Boger RH (2007) The pharmacodynamics of l-arginine. J Nutr 137:1650S-1655S
-
(2007)
J Nutr
, vol.137
-
-
Boger, R.H.1
-
5
-
-
34249788716
-
Arginine metabolism: Boundaries of our knowledge
-
1:CAS:528:DC%2BD2sXmt1ertr0%3D 17513435
-
Morris SM Jr (2007) Arginine metabolism: boundaries of our knowledge. J Nutr 137:1602S-1609S
-
(2007)
J Nutr
, vol.137
-
-
Morris, Jr.S.M.1
-
6
-
-
0027087177
-
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
-
10.1097/00005344-199204002-00018 1:CAS:528:DyaK3sXnslyhtw%3D%3D 1282988
-
Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20(Suppl 12):S60-S62
-
(1992)
J Cardiovasc Pharmacol
, vol.20
, Issue.SUPPL. 12
-
-
Vallance, P.1
Leone, A.2
Calver, A.3
Collier, J.4
Moncada, S.5
-
7
-
-
0242322346
-
Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia
-
10.1161/01.CIR.98.18.1842 1:CAS:528:DyaK1cXnsVWju7o%3D 9799202
-
Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O et al (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842-1847
-
(1998)
Circulation
, vol.98
, pp. 1842-1847
-
-
Boger, R.H.1
Bode-Boger, S.M.2
Szuba, A.3
Tsao, P.S.4
Chan, J.R.5
Tangphao, O.6
-
8
-
-
27744604586
-
Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
-
10.1515/CCLM.2005.196 16197309
-
Boger RH, Maas R, Schulze F, Schwedhelm E (2005) Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chem Lab Med 43:1124-1129
-
(2005)
Clin Chem Lab Med
, vol.43
, pp. 1124-1129
-
-
Boger, R.H.1
Maas, R.2
Schulze, F.3
Schwedhelm, E.4
-
9
-
-
33747186695
-
ADMA increases arterial stiffness and decreases cerebral blood flow in humans
-
10.1161/01.STR.0000231640.32543.11 16809568
-
Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, Martens-Lobenhoffer J et al (2006) ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37:2024-2029
-
(2006)
Stroke
, vol.37
, pp. 2024-2029
-
-
Kielstein, J.T.1
Donnerstag, F.2
Gasper, S.3
Menne, J.4
Kielstein, A.5
Martens-Lobenhoffer, J.6
-
10
-
-
68749084935
-
Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort
-
10.1161/STROKEAHA.109.552539 1:CAS:528:DC%2BD1MXoslOltL0%3D 19498184
-
Maas R, Xanthakis V, Polak JF, Schwedhelm E, Sullivan LM, Benndorf R et al (2009) Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke 40:2715-2719
-
(2009)
Stroke
, vol.40
, pp. 2715-2719
-
-
Maas, R.1
Xanthakis, V.2
Polak, J.F.3
Schwedhelm, E.4
Sullivan, L.M.5
Benndorf, R.6
-
11
-
-
0036156916
-
Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease
-
10.1097/01.ASN.0000032548.18973.0F 1:CAS:528:DC%2BD38XhtlWisr4%3D 11805179
-
Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS et al (2002) Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13:490-496
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 490-496
-
-
Zoccali, C.1
Benedetto, F.A.2
Maas, R.3
Mallamaci, F.4
Tripepi, G.5
Malatino, L.S.6
-
12
-
-
65249119330
-
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community
-
10.1161/CIRCULATIONAHA.108.838268 19289633
-
Boger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ et al (2009) Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119:1592-1600
-
(2009)
Circulation
, vol.119
, pp. 1592-1600
-
-
Boger, R.H.1
Sullivan, L.M.2
Schwedhelm, E.3
Wang, T.J.4
Maas, R.5
Benjamin, E.J.6
-
13
-
-
27744511357
-
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: Results from the AtheroGene Study
-
10.1161/01.RES.0000181286.44222.61 1:CAS:528:DC%2BD2MXpsVWrurc%3D 16100045
-
Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C et al (2005) Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97:e53-e59
-
(2005)
Circ Res
, vol.97
-
-
Schnabel, R.1
Blankenberg, S.2
Lubos, E.3
Lackner, K.J.4
Rupprecht, H.J.5
Espinola-Klein, C.6
-
14
-
-
33747397670
-
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study
-
10.1016/j.ahj.2006.06.005
-
Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Goudeva L et al (2006) Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 152:493e1-493e8
-
(2006)
Am Heart J
, vol.152
-
-
Schulze, F.1
Lenzen, H.2
Hanefeld, C.3
Bartling, A.4
Osterziel, K.J.5
Goudeva, L.6
-
15
-
-
0035936406
-
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
-
10.1016/S0140-6736(01)07217-8 1:CAS:528:DC%2BD38XitV2gsQ%3D%3D 11784625
-
Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L et al (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113-2117
-
(2001)
Lancet
, vol.358
, pp. 2113-2117
-
-
Zoccali, C.1
Bode-Boger, S.2
Mallamaci, F.3
Benedetto, F.4
Tripepi, G.5
Malatino, L.6
-
16
-
-
33645473328
-
Symmetrical dimethylarginine: A new combined parameter for renal function and extent of coronary artery disease
-
10.1681/ASN.2005101119 16481412
-
Bode-Boger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M et al (2006) Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 17:1128-1134
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1128-1134
-
-
Bode-Boger, S.M.1
Scalera, F.2
Kielstein, J.T.3
Martens-Lobenhoffer, J.4
Breithardt, G.5
Fobker, M.6
-
17
-
-
0031424947
-
Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hCAT-2B
-
10.1006/niox.1996.0106 1:CAS:528:DyaK2sXislaht7c%3D 9701046
-
Closs EI, Basha FZ, Habermeier A, Forstermann U (1997) Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1:65-73
-
(1997)
Nitric Oxide
, vol.1
, pp. 65-73
-
-
Closs, E.I.1
Basha, F.Z.2
Habermeier, A.3
Forstermann, U.4
-
18
-
-
69249096129
-
Asymmetric dimethylarginine and symmetric dimethylarginine: Axis of evil or useful alliance?
-
10.1111/j.1525-139X.2009.00578.x 19708979
-
Kielstein JT, Fliser D, Veldink H (2009) Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 22:346-350
-
(2009)
Semin Dial
, vol.22
, pp. 346-350
-
-
Kielstein, J.T.1
Fliser, D.2
Veldink, H.3
-
19
-
-
70450245459
-
Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study
-
10.1016/j.atherosclerosis.2009.05.011 1:CAS:528:DC%2BD1MXhsFSgsLzN 19501358
-
Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M et al (2009) Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. Atherosclerosis 207:541-545
-
(2009)
Atherosclerosis
, vol.207
, pp. 541-545
-
-
Aucella, F.1
Maas, R.2
Vigilante, M.3
Tripepi, G.4
Schwedhelm, E.5
Margaglione, M.6
-
20
-
-
74749108725
-
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
-
10.1016/j.atherosclerosis.2009.06.039 1:CAS:528:DC%2BC3cXhtlyqsLY%3D 19700158
-
Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA et al (2010) Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis 208:518-523
-
(2010)
Atherosclerosis
, vol.208
, pp. 518-523
-
-
Schulze, F.1
Carter, A.M.2
Schwedhelm, E.3
Ajjan, R.4
Maas, R.5
Von Holten, R.A.6
-
21
-
-
69849106418
-
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: Potential mechanisms beyond nitric oxide synthase inhibition
-
10.1161/ATVBAHA.109.185645 1:CAS:528:DC%2BD1MXpsFykt7g%3D 19542023
-
Wang Z, Tang WH, Cho L, Brennan DM, Hazen SL (2009) Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 29:1383-1391
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 1383-1391
-
-
Wang, Z.1
Tang, W.H.2
Cho, L.3
Brennan, D.M.4
Hazen, S.L.5
-
22
-
-
78650993607
-
Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: The Ludwigshafen Risk and Cardiovascular Health study
-
10.1373/clinchem.2010.150854 1:CAS:528:DC%2BC3MXitFSksrw%3D 21036946
-
Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO et al (2011) Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 57:112-121
-
(2011)
Clin Chem
, vol.57
, pp. 112-121
-
-
Meinitzer, A.1
Kielstein, J.T.2
Pilz, S.3
Drechsler, C.4
Ritz, E.5
Boehm, B.O.6
-
23
-
-
77649091020
-
Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association
-
10.1161/CIRCULATIONAHA.109.192666 20177011
-
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G et al (2010) Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:948-954
-
(2010)
Circulation
, vol.121
, pp. 948-954
-
-
Lloyd-Jones, D.1
Adams, R.J.2
Brown, T.M.3
Carnethon, M.4
Dai, S.5
De Simone, G.6
-
24
-
-
33745965348
-
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress
-
10.1161/01.ATV.0000222983.73369.c8 1:CAS:528:DC%2BD28XmvFyjur0%3D 16627803
-
Koenig W, Twardella D, Brenner H, Rothenbacher D (2006) Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol 26:1586-1593
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 1586-1593
-
-
Koenig, W.1
Twardella, D.2
Brenner, H.3
Rothenbacher, D.4
-
25
-
-
33845506828
-
Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease
-
10.1001/archinte.166.22.2455 1:CAS:528:DC%2BD2sXls1yhtg%3D%3D 17159010
-
Rothenbacher D, Koenig W, Brenner H (2006) Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med 166:2455-2460
-
(2006)
Arch Intern Med
, vol.166
, pp. 2455-2460
-
-
Rothenbacher, D.1
Koenig, W.2
Brenner, H.3
-
26
-
-
34248190179
-
High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma
-
10.1016/j.jchromb.2006.11.052 1:CAS:528:DC%2BD2sXlt1aktLs%3D 17194630
-
Schwedhelm E, Maas R, Tan-Andresen J, Schulze F, Riederer U, Boger RH (2007) High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci 851:211-219
-
(2007)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.851
, pp. 211-219
-
-
Schwedhelm, E.1
Maas, R.2
Tan-Andresen, J.3
Schulze, F.4
Riederer, U.5
Boger, R.H.6
-
27
-
-
23444448460
-
Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma
-
10.1373/clinchem.2004.046037 1:CAS:528:DC%2BD2MXlsleqsLk%3D 15976109
-
Schwedhelm E, Tan-Andresen J, Maas R, Riederer U, Schulze F, Boger RH (2005) Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma. Clin Chem 51:1268-1271
-
(2005)
Clin Chem
, vol.51
, pp. 1268-1271
-
-
Schwedhelm, E.1
Tan-Andresen, J.2
Maas, R.3
Riederer, U.4
Schulze, F.5
Boger, R.H.6
-
28
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
19414839
-
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612
-
(2009)
Ann Intern Med
, vol.150
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
Zhang, Y.L.4
Castro III, A.F.5
Feldman, H.I.6
-
29
-
-
77950874403
-
Dose-response analyses using restricted cubic spline functions in public health research
-
20087875
-
Desquilbet L, Mariotti F (2010) Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29:1037-1057
-
(2010)
Stat Med
, vol.29
, pp. 1037-1057
-
-
Desquilbet, L.1
Mariotti, F.2
-
30
-
-
34547682138
-
New predictive equations improve monitoring of kidney function in patients with diabetes
-
10.2337/dc06-2637 17536079
-
Beauvieux MC, Le Moigne F, Lasseur C, Raffaitin C, Perlemoine C, Barthe N et al (2007) New predictive equations improve monitoring of kidney function in patients with diabetes. Diabetes Care 30:1988-1994
-
(2007)
Diabetes Care
, vol.30
, pp. 1988-1994
-
-
Beauvieux, M.C.1
Le Moigne, F.2
Lasseur, C.3
Raffaitin, C.4
Perlemoine, C.5
Barthe, N.6
-
31
-
-
70349501468
-
Glomerular filtration rate measurement and prediction equations
-
10.1515/CCLM.2009.263 1:CAS:528:DC%2BD1MXht1GjtbjN 19728843
-
Soares AA, Eyff TF, Campani RB, Ritter L, Camargo JL, Silveiro SP (2009) Glomerular filtration rate measurement and prediction equations. Clin Chem Lab Med 47:1023-1032
-
(2009)
Clin Chem Lab Med
, vol.47
, pp. 1023-1032
-
-
Soares, A.A.1
Eyff, T.F.2
Campani, R.B.3
Ritter, L.4
Camargo, J.L.5
Silveiro, S.P.6
-
32
-
-
73249118905
-
Oral l-arginine supplementation in acute myocardial infarction therapy: A meta-analysis of randomized controlled trials
-
10.1002/clc.20616 19938054
-
Sun T, Zhou WB, Luo XP, Tang YL, Shi HM (2009) Oral l-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials. Clin Cardiol 32:649-652
-
(2009)
Clin Cardiol
, vol.32
, pp. 649-652
-
-
Sun, T.1
Zhou, W.B.2
Luo, X.P.3
Tang, Y.L.4
Shi, H.M.5
-
33
-
-
77954314513
-
Prognostic value of chronic kidney disease in patients with coronary heart disease: Role of estimating equations
-
10.1016/j.atherosclerosis.2010.02.028 1:CAS:528:DC%2BC3cXos1yiu7c%3D 20347445
-
Zhang QL, Brenner H, Koenig W, Rothenbacher D (2010) Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations. Atherosclerosis 211:342-347
-
(2010)
Atherosclerosis
, vol.211
, pp. 342-347
-
-
Zhang, Q.L.1
Brenner, H.2
Koenig, W.3
Rothenbacher, D.4
-
34
-
-
77952067397
-
Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine
-
10.2353/ajpath.2010.090614 1:CAS:528:DC%2BC3cXmvFWjsr8%3D 20348244
-
Jacobi J, Maas R, Cardounel AJ, Arend M, Pope AJ, Cordasic N et al (2010) Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine. Am J Pathol 176:2559-2570
-
(2010)
Am J Pathol
, vol.176
, pp. 2559-2570
-
-
Jacobi, J.1
Maas, R.2
Cardounel, A.J.3
Arend, M.4
Pope, A.J.5
Cordasic, N.6
|